BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 18045780)

  • 1. Therapeutic drug monitoring of cancer chemotherapy.
    Alnaim L
    J Oncol Pharm Pract; 2007 Dec; 13(4):207-21. PubMed ID: 18045780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs.
    Rousseau A; Marquet P
    Fundam Clin Pharmacol; 2002 Aug; 16(4):253-62. PubMed ID: 12570013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring in cancer chemotherapy.
    Bach DM; Straseski JA; Clarke W
    Bioanalysis; 2010 May; 2(5):863-79. PubMed ID: 21083218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics and therapeutic drug monitoring of anticancer agents].
    Marquet P; Rousseau A
    Bull Cancer; 2008 Oct; 95(10):903-9. PubMed ID: 19004719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target concentration intervention in oncology: where are we at?
    Saleem M; Dimeski G; Kirkpatrick CM; Taylor PJ; Martin JH
    Ther Drug Monit; 2012 Jun; 34(3):257-65. PubMed ID: 22585183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.
    Paci A; Veal G; Bardin C; Levêque D; Widmer N; Beijnen J; Astier A; Chatelut E
    Eur J Cancer; 2014 Aug; 50(12):2010-9. PubMed ID: 24889915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
    Baumann P; Hiemke C; Ulrich S; Eckermann G; Gaertner I; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G;
    Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive control methods for the dose individualisation of anticancer agents.
    Rousseau A; Marquet P; Debord J; Sabot C; Lachâtre G
    Clin Pharmacokinet; 2000 Apr; 38(4):315-53. PubMed ID: 10803455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring in cancer--are we missing a trick?
    Bardin C; Veal G; Paci A; Chatelut E; Astier A; Levêque D; Widmer N; Beijnen J
    Eur J Cancer; 2014 Aug; 50(12):2005-9. PubMed ID: 24878063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making TDM work to optimize cancer chemotherapy: a multidisciplinary team approach.
    Hon YY; Evans WE
    Clin Chem; 1998 Feb; 44(2):388-400. PubMed ID: 9474050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug stability and compatibility in oncology care.
    Williams DA
    J Infus Chemother; 1996; 6(4):195-202. PubMed ID: 9229315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
    Wallemacq P; Armstrong VW; Brunet M; Haufroid V; Holt DW; Johnston A; Kuypers D; Le Meur Y; Marquet P; Oellerich M; Thervet E; Toenshoff B; Undre N; Weber LT; Westley IS; Mourad M
    Ther Drug Monit; 2009 Apr; 31(2):139-52. PubMed ID: 19177031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic-pharmacokinetic relationships and therapeutic drug monitoring.
    Kobayashi K; Jodrell DI; Ratain MJ
    Cancer Surv; 1993; 17():51-78. PubMed ID: 8137353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of antidepressants--clinical aspects.
    Laux G; Baumann P; Hiemke C;
    J Neural Transm Suppl; 2007; (72):261-7. PubMed ID: 17982902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic determinants of the activity and toxicity of antitumour agents.
    Newell DR
    Cancer Surv; 1989; 8(3):557-603. PubMed ID: 2701085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic drug monitoring: clinical practice].
    Widmer N; Werner D; Grouzmann E; Eap CB; Marchetti O; Fayet A; Csajka C; Decosterd LA; Buclin T
    Rev Med Suisse; 2008 Jul; 4(165):1649-50, 1652-60. PubMed ID: 18767291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects].
    Marquet P
    Acta Clin Belg; 1999; 53 Suppl 1():2-12. PubMed ID: 10216973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functions of the 'Therapeutic Drug Monitoring (TDM)' Group of the French Society of Pharmacology].
    Marquet P;
    Therapie; 2001; 56(3):235-7. PubMed ID: 11475800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Principles of therapeutic drug monitoring].
    Widmer N; Csajka C; Werner D; Grouzmann E; Decosterd LA; Eap CB; Biollaz J; Buclin T
    Rev Med Suisse; 2008 Jul; 4(165):1644-8. PubMed ID: 18767290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.